Hypercortisolemia decreases dexamethasone half-life in rabbit

Journal of Psychiatric Research

Volumn 36, Issue 6, 2002, Pages 423-428

  Stokes, P E ^a   Stoll, P M ^a   Schluger, J H ^a   Lasley, B ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Depression; Dexamethasone; Dexamethasone half life; DST; Hypercortisolemia

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE; HYDROCORTISONE ACETATE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; HYDROCORTISONE BLOOD LEVEL; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0036830050     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(02)00012-2     Document Type: Article

References (19)

1. Araki Y., Yokota O., Kato T., Kashima M., Miyazaki T. Dynamics of synthetic corticosteroids in man. Pincus G., Nakao T., Tait J.F. Steroid dynamics. 1966;474-477 Academic Press, New York.
2. Arana G.W., Workman R.J., Baldessarini R.J. Association between low plasma levels of dexamethasone and elevated levels of cortisol in psychiatric patients given dexamethasone. American Journal of Psychiatry. 141:1984;1619-1620.
3. Arana G.W., Baldessarini R.J., Ornsteen M. The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Commentary and review. Archives of General Psychiatry. 42:1985;1193-1204.
4. Berger M., Pirke K.M., Doerr P., Krieg J.C., von Zerssen D. The limited utility of the dexamethasone suppression test for the diagnostic process in psychiatry. British Journal of Psychiatry. 145:1984;372-382.
5. Casper R.C., Swann A.C., Stokes P.E., Chang S., Katz M.M., Garver D. Weight loss, cortisol levels, and dexamethasone suppression in major depressive disorder. Acta Psychiatrica Scandinavia. 75:1987;243-250.
6. Cassidy F., Ritchie J.C., Verghese K., Carroll B.J. Dexamethasone metabolism in dexamethasone suppression test suppressors and nonsuppressors. Biological Psychiatry. 47:2000;677-680.
7. Duman R.S., Nakagawa S., Malberg J. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology. 25(6):2001;836-844.
8. Haque N., Thrasher K., Werk E.E., Knowles H.C., Sholiton L.J. Studies on dexamethasone metabolism in man: effect of diphenylhydantoin. Journal of Clinical Endocrinology. 34(1):1972;44-50.
9. Holsboer F., Wiedemann K., Gerken A., Boll E. The Plasma dexamethasone variable in depression: test-retest studies and early biophase kinetics. Psychiatry Research. 17(2):1986;97-103.
10. Horwith M., Stokes P.E. Cushing's syndrome experience with total adrenalectomy. Dock W., Snapper I. Advances in internal medicine, vol. X. 1960;259-295 The Year Book Publishers, Chicago.
11. Johnson G.F., Hunt G., Lerr K., Caterson I. Dexamethasone suppression test (DST) and plasma dexamethasone levels in depressed patients. Psychiatry Research. 13:1984;305-313.
12. Morris H., Carr V., Gilliland J., Hooper M. Dexamethasone concentrations and the dexamethasone suppression test in psychiatric disorders. British Journal of Psychiatry. 148:1986;66-69.
13. Poland R.E., Rubin R.T., Lesser I.M., Lane L.A., Hart P.J. Neuroendocrine aspects of primary endogenous depression:II. Serum dexamethasone concentrations and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response. Archives of General Psychiatry. 44:1987;790-795.
14. Simmons P.S., Miles J.M., Gerich J.E., Haymond M.W. Increased proteolysis: An effect of increases in plasma cortisol within the physiologic range. Journal of Clinical Investigation. 73:1984;412.
15. Stokes P.E. The potential role of excessive cortisol induced by HPA hyperfunction in the pathogenesis of depression. European Neuropsychopharmacology. Suppl:5:1995;77-82.
16. Stokes PE, Sikes CR, Stoll PM, Lasley BJ. Dexamethasone half-life affects DST response. Presented at the 42nd Annual Meeting of the Society of Biological Psychiatry, Chicago, IL May, 1987.
17. Stokes P.E., Stoll P.M., Koslow S.H., Maas J.W., Davis J.M., Swann A.C., Robins E. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. Archives of General Psychiatry. 41:1984;257.
18. Stokes P.E., Stoll P.M., Mattson M.R., Sollod R.N. Diagnosis and psychopathology in psychiatric patients resistant to dexamethasone. Sachar E.J. Hormones, behavior, and psychopathology. 1976;225-229 Raven Press, New York.
19. Wiedemann K., Holsboer F. Plasma dexamethasone kinetics during the DST after oral and intravenous administration of the test drug. Biological Psychiatry. 22:1987;1340-1348.